药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Heptabarbital
Tetrahydropalmatine
The risk or severity of QTc prolongation can be increased when Tetrahydropalmatine is combined with Lenvatinib.
Heptabarbital
Delafloxacin
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Lenvatinib.
Heptabarbital
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Lenvatinib.
Heptabarbital
CUDC-907
The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Lenvatinib.
Heptabarbital
Anisodamine
The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Lenvatinib.
Heptabarbital
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Lenvatinib.
Heptabarbital
Talinolol
The risk or severity of QTc prolongation can be increased when Talinolol is combined with Lenvatinib.
Heptabarbital
Rupatadine
The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Lenvatinib.
Heptabarbital
Bilastine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Lenvatinib.
Heptabarbital
Difloxacin
The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Lenvatinib.
Heptabarbital
Sarafloxacin
The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Lenvatinib.
Heptabarbital
Phosmet
The risk or severity of QTc prolongation can be increased when Phosmet is combined with Lenvatinib.
Heptabarbital
Orbifloxacin
The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Lenvatinib.
Heptabarbital
Fenthion
The risk or severity of QTc prolongation can be increased when Fenthion is combined with Lenvatinib.
Heptabarbital
Famphur
The risk or severity of QTc prolongation can be increased when Famphur is combined with Lenvatinib.
Heptabarbital
Dichlorvos
The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Lenvatinib.
Heptabarbital
Coumaphos
The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Lenvatinib.
Heptabarbital
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Lenvatinib.
Heptabarbital
Lacidipine
The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Lenvatinib.
Heptabarbital
Efonidipine
The risk or severity of QTc prolongation can be increased when Efonidipine is combined with Lenvatinib.